Dino Collavo

Affiliations: 
Institute of Oncology University of Padua (Italy) 
Google:
"Dino Collavo"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rosato A, Milan G, Zambon A, et al. (2000) CTL Analysis for Tumor Vaccines. Methods in Molecular Medicine. 29: 123-32
Rosato A, Milan G, Collavo D, et al. (1999) DNA-based vaccination against tumors expressing the P1A antigen. Methods (San Diego, Calif.). 19: 187-90
Quintieri L, Rosato A, Amboldi N, et al. (1999) Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases. British Journal of Cancer. 79: 1067-73
Milan G, Zambon A, Cavinato M, et al. (1999) Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach. Journal of Virology. 73: 2280-7
Milan G, Rosato A, Zambon A, et al. (1998) DNA immunization in mice against virus-induced tumor antigens. Advances in Experimental Medicine and Biology. 451: 311-4
Vizler C, Rosato A, Calderazzo F, et al. (1998) Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity. British Journal of Cancer. 77: 656-62
Rosato A, Zambon A, Milan G, et al. (1997) CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. Human Gene Therapy. 8: 1451-8
Macino B, Zambon A, Milan G, et al. (1996) CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes. Biochemical and Biophysical Research Communications. 226: 769-76
Monastra G, Cabrelle A, Zambon A, et al. (1996) Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells. Cellular Immunology. 171: 102-10
Rosato A, Zambon A, Macino B, et al. (1996) Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. International Journal of Cancer. 65: 847-51
See more...